LIANY — LianBio Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousMicro Cap
- $21.43m
- -$197.01m
Annual cashflow statement for LianBio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -24.3 | -140 | -196 | -110 |
| Depreciation | ||||
| Non-Cash Items | 9.52 | 41.2 | 18 | 2.1 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 3.12 | 0.171 | 13.8 | 8 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -11.7 | -98.1 | -164 | -99.2 |
| Capital Expenditures | 0 | -0.886 | -0.947 | -1.84 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | — | — | -155 | -67.4 |
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Cash from Investing Activities | 0 | -0.886 | -156 | -69.2 |
| Financing Cash Flow Items | 0 | -0.036 | -6.3 | 0 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 55 | 310 | 313 | 1.71 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 43.3 | 211 | -6.17 | -169 |